An NIH-sponsored clinical trial for people with scleroderma.
Living with scleroderma?
The BRAVOS study may be an option for you.
About Bravos
A clinical trial evaluating Brentuximab Vendotin treatment for Diffuse Cutaneous Systemic Sclerosis.